Promacta - Drug Details
๐Ÿ“Š Estimates Promacta Dialyzability By Different_Modalities

Promacta

Complete Drug Information

Drug Name
Promacta
Trade Names
Promacta, Revolade
Pregnancy Category
AU: B3
Bioavailability
~52%
Routes of Administration
Oral
Protein Binding
>99%%
Metabolism
extensive liver (through CYP1A2 and CYP2C8)
Elimination
21โ€“35 hours
Excretion
feces (59%), urine (31%)
Formula
C25H22N4O4
Molar Mass
442.475
Volume of Distribution
C25H22N4O4

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.